Immediate Impact
2 from Science/Nature 62 standout
Citing Papers
Cross-priming in cancer immunology and immunotherapy
2025 Standout
Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer
2025 Standout
Works of Ken Hatogai being referenced
Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
2024
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ken Hatogai | 232 | 281 | 226 | 34 | 519 | |
| Jia Song | 127 | 216 | 377 | 24 | 607 | |
| Massimo Framarini | 265 | 204 | 130 | 39 | 533 | |
| Yuta Kasagi | 360 | 255 | 143 | 36 | 581 | |
| Mitsuhiko Iwamoto | 134 | 130 | 254 | 42 | 525 | |
| Taiyuan Li | 298 | 100 | 368 | 42 | 498 | |
| M Shimotsuma | 260 | 148 | 135 | 26 | 491 | |
| Shuisheng Zhang | 152 | 219 | 199 | 33 | 507 | |
| Takanobu Tabuchi | 196 | 142 | 272 | 26 | 468 | |
| Jie Yue | 225 | 214 | 125 | 50 | 626 | |
| Woo Ram Kim | 174 | 81 | 268 | 31 | 479 |
All Works
Login with ORCID to disown or claim papers
Loading papers...